The 2011 Top Ten World’s Leading Pharmaceutical Companies

Date: October 22, 2010
Pages: 1200
Price:
US$ 13,200.00 US$ 11,220.00
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T318ECAB391EN
Leaflet:

Download PDF Leaflet

The 2011 Top Ten World’s Leading Pharmaceutical Companies
Global PDF: US$ 29,00.000

A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report’s major objectives include:
  • To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading pharmaceutical companies.
  • To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors.
  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations’ internal competitor information gathering efforts by providing strategic analysis, data interpretation and insight.
  • To identify the least competitive market niches with significant growth potential.
Contains 1,200 pages and 100 tables
SECTION I: EXECUTIVE SUMMARY

A 5-10 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION

History of the company’s pharmaceutical business evolution, which is important to understanding the corporate culture, management mentality, and strategies.
Most recent M&A activity and significant organizational changes.
Current organizational structure.

SECTION III: SENIOR MANAGEMENT

Names, titles, and background of senior managers.

SECTION IV: FACILITIES AND EMPLOYEES

Major administrative, manufacturing, and R&D facilities in the U.S. and abroad.
Manufacturing practices.
New plants under construction.
U.S. and international work force size and distribution.

SECTION V:TECHNOLOGICAL KNOW-HOW

Internally developed and acquired technologies, processes, and related capabilities.
Know-how in biotechnology and other pertinent fields.
Proprietary technologies and patent litigations.

SECTION VI: PRODUCT PORTFOLIO ANALYSIS

Extensive review of major ethical, OTC, and generic drugs.
Most recent new drug introductions and indications.

SECTION VII: MARKETING TACTICS

Sales force in the U.S., Europe, and other regions.
Distribution strategies.
Major promotional tactics.

SECTION VIII: FINANCIAL ANALYSIS

The U.S. and international sales and operating profit estimates by division, geographic region, therapeutic category, and individual drug.
The five-year sales and operating profit performance.

SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS

The R&D budget.
Research facilities and staff.
New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.
Worldwide sales force size.

SECTION X: COLLABORATIVE ARRANGEMENTS

Major joint venture, distribution, OEM, and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION

Major strengths and weaknesses.
Business, new product development, and marketing objectives and strategies.
Anticipated acquisitions, joint ventures, and divestitures.

LIST OF TABLES

Table MO-1: World Pharmaceutical Market by Major Product Segment
Table MO-2: World Ethical Pharmaceutical Market by Geographic Region/Country
Table MO-3: World Ethical Pharmaceutical Market by Major Drug Category
Table AZ-1: AstraZeneca Sales and Operating Profit Growth
Table AZ-2: AstraZeneca Sales by Therapeutic Category/Business
Table AZ-3: AstraZeneca Sales Growth by Therapeutic Category/Business
Table AZ-4: AstraZeneca Sales by Major Drug/Business
Table AZ-5: AstraZeneca Sales Growth by Major Drug/Business
Table AZ-6: AstraZeneca Sales by Major Drug/Business and Geographic Region
Table AZ-7: AstraZeneca Sales by Geographic Region and Country
Table AZ-8: AstraZeneca Sales Growth by Geographic Region and Country
Table BM-1: Bristol-Myers Squibb Sales and Operating Profit Growth
Table BM-2: Bristol-Myers Squibb Sales by Major Division
Table BM-3: Bristol-Myers Squibb Sales by Major Division and Geographic Region
Table BM-4: Bristol-Myers Squibb Sales Growth by Major Division
Table BM-5: Bristol-Myers Squibb Sales by Therapeutic Category
Table BM-6: Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region
Table BM-7: Bristol-Myers Squibb Sales Growth by Therapeutic Category
Table BM-8: Bristol-Myers Squibb Sales by Major Drug
Table BM-9: Bristol-Myers Squibb Sales Growth by Major Drug
Table BM-10: Bristol-Myers Squibb Sales by Product Line
Table BM-11: Bristol-Myers Squibb Sales Growth by Product Line
Table BM-12: Bristol-Myers Squibb Sales by Geographic Region
Table BM-13: Bristol-Myers Squibb Sales Growth by Geographic Region
Table BM-14: Bristol-Myers Squibb Other Health Care Sales by Product
Table GL-1: GlaxoSmithKline Sales by Business Segment
Table GL-2: GlaxoSmithKline Sales Growth by Business Segment
Table GL-3: GlaxoSmithKline Operating Profit And Margins by Business Segment
Table GL-4: GlaxoSmithKline Operating Profit by Business Segment
Table GL-5: GlaxoSmithKline Sales and Operating Profit Growth
Table GL-6: GlaxoSmithKline Sales by Major Drug
Table GL-7: GlaxoSmithKline Sales by Drug and Geographic Region
Table GL-8: GlaxoSmithKline Sales by Therapeutic Category
Table GL-9: GlaxoSmithKline Sales Growth by Therapeutic Category
Table GL-10: GlaxoSmithKline Sales by Geographic Region and Country
Table GL-11: GlaxoSmithKline Sales Growth by Geographic Region
Table GL-12: GlaxoSmithKline Consumer Healthcare Sales by Product Line
Table GL-13: GlaxoSmithKline Consumer Healthcare Sales Growth by Product Line
Table JJ-1: Johnson & Johnson Sales by Geographic Region and Country
Table JJ-2: Johnson & Johnson Sales Growth by Geographic Region
Table JJ-3: Johnson & Johnson Sales by Business Segment and Geographic Region
Table JJ-4: Johnson & Johnson Sales and Operating Profit Growth
Table JJ-5: Johnson & Johnson Sales by Major Drug
Table JJ-6: Johnson & Johnson Pharmaceutical Sales Growth by Major Drug
Table JJ-7: Johnson & Johnson Consumer Segment Sales by Product Line
Table JJ-8: Johnson & Johnson Consumer Segment Sales Growth by Product Line
Table ME-1: Merck Sales and Operating Profit Growth
Table ME-2: Merck Sales by Geographic Region
Table ME-3: Merck Sales Growth by Geographic Region
Table ME-4: Merck Sales by Therapeutic Category
Table ME-5: Merck Sales Growth by Therapeutic Category
Table ME-6: Merck Sales By Major Drug
Table ME-7: Merck Sales Growth by Major Drug
Table ME-8: Merck Sales By Major Drug and Geographic Region
Table NO-1: Novartis Sales and Operating Profit Growth
Table NO-2: Novartis Sales by Business Segment
Table NO-3: Novartis Sales Growth by Business Segment
Table NO-4: Novartis Operating Profit by Business Segment
Table NO-5: Novartis Operating Profit Growth by Business Segment
Table NO-6: Novartis Sales by Country
Table NO-7: Novartis Sales Growth by Country
Table NO-8: Novartis Sales by Therapeutic Category
Table NO-9: Novartis Sales Growth by Therapeutic Category
Table NO-10: Novartis Sales of Top 20 Drugs
Table NO-11: Novartis Sales Growth by Major Drug
Table PF-1: Pfizer Sales by Division
Table PF-2: Pfizer Sales and Operating Profit Growth
Table PF-3: Pfizer Sales by Therapeutic Category
Table PF-4: Pfizer Sales by Major Product
Table PF-5: Pfizer Sales Growth by Major Product
Table PF-6: Pfizer Sales by Geographic Region
Table PF-7: Pfizer Sales Growth by Geographic Region
Table RO-1: Roche Sales and Operating Profit Growth
Table RO-2: Roche Sales by Major Division
Table RO-3: Roche Sales Growth by Business Segment
Table RO-4: Roche Sales by Geographic Region
Table RO-5: Roche Sales Growth by Geographic Region
Table RO-6: Roche Sales and Operating Profit Growth
Table RO-7: Roche Sales by Division
Table RO-8: Roche Operating Profit by Division
Table RO-9: Roche Operating Profit Growth by Division
Table RO-10: Roche Sales by Therapeutic Category
Table RO-11: Roche Sales of Top 20 Products
Table SA-1: Sanofi-Aventis Sales and Operating Profit Growth
Table SA-2: Sanofi-Aventis Sales by Business Segment
Table SA-3: Sanofi-Aventis Sales Growth by Business Segment
Table SA-4: Sanofi-Aventis Sales of Top 15 Drugs
Table SA-5: Sanofi-Aventis Sales Growth of Top 15 Drugs
Table SA-6: Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region
Table SA-7: Sanofi-Aventis Sales by Geographic Region
Table SA-8: Sanofi-Aventis Vaccine Sales by Major Product
Table WY-1: Wyeth Sales by Business Segment
Table WY-2: Wyeth Sales Growth by Business Segment
Table WY-3: Wyeth Sales and Operating Profit Growth
Table WY-4: Wyeth Sales by Therapeutic Category
Table WY-5: Wyeth Sales by Major Drug
Table WY-6: Wyeth Consumer Healthcare Sales by Product
Table WY-7: Wyeth Consumer Healthcare Sales Growth by Product
Table CA-1: The Top 10 World’s Leading Pharmaceutical Companies Sales, Rank, and Market Share
Table CA-2: The Top 10 World’s Leading Pharmaceutical Companies Operating Profit, Margins, and Rank
Table CA-3: The Top 10 World’s Leading Pharmaceutical Companies R&D Expenditures, Percent of Sales, and Rank
Skip to top


Ask Your Question

The 2011 Top Ten World’s Leading Pharmaceutical Companies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: